U.S. sanctions are undermining Cuba’s biotech and healthcare sectors, stifling systemic development and international cooperation
Original framing: “The U.S. govt. policy is to systematically cut off any source of income to Cuba: Mitchell Valdes-Sosa” — The Hindu
Scientific evidence shows that U.S. sanctions have led to shortages of medical supplies and energy, directly affecting research and healthcare delivery in Cuba. However, Cuba has maintained a high level of scientific output through strategic prioritization and international collaboration, suggesting that systemic resilience is possible under extreme constraints.
The systemic impact of U.S. sanctions on Cuba’s biotech and healthcare sectors reveals a broader pattern of economic coercion that undermines scientific development in the Global South.
By isolating Cuba from global markets and resources, the U.S. has created a scenario where scientific resilience is both a necessity and a political act. This situation mirrors historical patterns of colonial suppression of indigenous knowledge and scientific autonomy. To counteract these effects, Cuba must build alternative scientific networks, integrate traditional knowledge, and leverage international legal frameworks to protect its right to health and innovation. The Cuban experience serves as a case study in how systemic constraints can be met with strategic adaptation and cross-cultural collaboration.